# Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study

> **NCT03938441** · NA · TERMINATED · sponsor: **gino gaddini** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Type 2
- Pre-diabetes

## Interventions

- **OTHER:** Intermittent Fasting

## Key facts

- **NCT ID:** NCT03938441
- **Lead sponsor:** gino gaddini
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-31
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-05-28
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Slow enrollment and PI Graduating Residency in June 2021.
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03938441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03938441, "Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03938441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*